Standout Papers
Citation Impact
Citing Papers
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
2010
Micro RNA mimicry blocks pulmonary fibrosis
2014
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
2009
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
2009 Science
Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice
2011
miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival
2011
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
2011
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
2014
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
2013
Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non‐alcoholic fatty liver disease
2013
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
2009
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
2012
Hallmarks of Cancer: The Next Generation
2011 Standout
Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis
2017
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Mir-34: A New Weapon Against Cancer?
2014
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Effects of Liver Biopsy Sample Length and Number of Readings on Sampling Variability in Nonalcoholic Fatty Liver Disease
2008
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Mucin Profiles in Signet-ring Cell Carcinoma
2006
Pathology of Nonalcoholic Fatty Liver Disease
2007
Liver Zonation Occurs Through a β-Catenin–Dependent, c-Myc–Independent Mechanism
2009
NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice
2006
Pathology of fatty liver disease
2007
Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution
2015
Pathogenesis and management issues for non-alcoholic fatty liver disease
2007
Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events
2012
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD)
2008
Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis
2015
Limitations of non-invasive tests for assessment of liver fibrosis
2020
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease
2016
Nonalcoholic Steatohepatitis in Children
2009
Association Between Puberty and Features of Nonalcoholic Fatty Liver Disease
2012
MYC on the Path to Cancer
2012 Standout
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
2016
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
2012 Standout
Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease
2009
Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
2008
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
2013
Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2015
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
2012
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
2003 Standout
A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease
2015
Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
2008
Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients
2013
Targeting microRNAs in cancer: rationale, strategies and challenges
2010
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study
2011
Biochemical Surrogate Markers of Liver Fibrosis and Activity in A Randomized Trial of Peginterferon Alfa–2B and Ribavirin
2003
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
2005 Standout
Energy metabolism in tumor cells
2007
Endpoints and clinical trial design for nonalcoholic steatohepatitis
2011
Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels
2013
Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis
2011
Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
2013
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
2006
Management of Hepatic Complications in HIV‐Infected Persons
2008
Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network
2011
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
2006 StandoutNobel
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
2015
AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication
2014
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
2009
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
2012
New insight in the pathobiology of hepatitis B virus infection
2012
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare
2017
State-of-the-art gene-based therapies: the road ahead
2011
Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease
2008
Hepatocellular carcinoma
2012 Standout
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
2012
A Molecular Signature to Discriminate Dysplastic Nodules From Early Hepatocellular Carcinoma in HCV Cirrhosis
2006
Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma
2012
Resolution of Nonalcoholic Steatohepatits after Gastric Bypass Surgery
2007
Pathological Features of Fatty Liver Disease
2014
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
2011
Liver biopsy†
2008
Effect of vitamin E on aminotransferase levels and insulin resistance in children with non‐alcoholic fatty liver disease
2006
A Combination of the Pediatric NAFLD Fibrosis Index and Enhanced Liver Fibrosis Test Identifies Children With Fibrosis
2010
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
2010 Standout
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
2014
Metabolic Syndrome Is Associated with Greater Histologic Severity, Higher Carbohydrate, and Lower Fat Diet in Patients with NAFLD
2006
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
2009
Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach
2007
Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis
2015
Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis
2009
The NAFLD fibrosis score
2007 Standout
Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
2015
Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
2008
A Genetic Defect in Exportin-5 Traps Precursor MicroRNAs in the Nucleus of Cancer Cells
2010
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
2010
Molecular and cellular mechanisms of liver fibrosis and its regression
2020
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile
2014
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
2006
The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
2009
Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease
2008
The Association of Genetic Variability in Patatin-Like Phospholipase Domain-Containing Protein 3 (PNPLA3) with Histological Severity of Nonalcoholic Fatty Liver Disease†
2010
Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
2012
MicroRNA-21 in Cardiovascular Disease
2010
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
The role of thiazolidinediones in non-alcoholic steatohepatitis – A systematic review and meta analysis
2011
Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
2011
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
2009
Clinical and Histological Features of Nonalcoholic Fatty Liver Disease in Children
2009
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
2011
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (Flirt 2) Extension Trial
2009
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
2011
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
2010
Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography
2013
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
2013
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
2015
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
2015
Causes and consequences of microRNA dysregulation in cancer
2009 Standout
Serum Ferritin Is An Independent Predictor of Histologic Severity and Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2011
The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome
2007
The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
2013
Role of Liver Biopsy in the Evaluation of Hepatitis C Virus Infection in HIV Coinfection
2005
Relationship Between Changes in Serum Levels of Keratin 18 and Changes in Liver Histology in Children and Adults With Nonalcoholic Fatty Liver Disease
2014
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
2013 Standout
Non-Alcoholic Fatty Liver Disease in Liver Transplant Recipients: Another Story of “Seed and Soil”
2009
Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
2009
Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §Δ
2010
Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
2008
Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
2008
Generation of germline-competent induced pluripotent stem cells
2007 StandoutNatureNobel
Transient Elastography for the Noninvasive Assessment of Liver Fibrosis: A Multicentre Canadian Study
2010
Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics
2006
Clinical features and outcomes of cirrhosis due to non‐alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C
2008
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Non-coding RNAs in human disease
2011 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center
2007
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
2007
NAFLD, NASH and liver cancer
2013
Histopathology of Pediatric Nonalcoholic Fatty Liver Disease * #
2005
Hepatic histology in obese patients undergoing bariatric surgery
2006
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
2009
Inflammatory Cytokine TNFα Promotes the Long-Term Expansion of Primary Hepatocytes in 3D Culture
2018
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH
2010
Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality
2011
Orlistat for overweight subjects with nonalcoholic steatohepatitis
2008
HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2009
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
2010
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis
2007
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
2012
Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism☆
2009
Highly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis
2008
Angiogenesis in liver disease
2009
Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile
2014
Advances in Pediatric Nonalcoholic Fatty Liver Disease†
2009
Lessons from animal models of NASH
2005
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis
2015
Noninvasive Differentiation of Simple Steatosis and Steatohepatitis by Using Gadoxetic Acid–enhanced MR Imaging in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study
2014
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis
2010
The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene
2005
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease
2008
Obstructive Sleep Apnea and Hypoxemia Are Associated with Advanced Liver Histology in Pediatric Nonalcoholic Fatty Liver Disease
2013
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2008
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Histopathologic Variability Between the Right and Left Lobes of the Liver in Morbidly Obese Patients Undergoing Roux-en-Y Bypass
2007
Exendin-4 Improves Steatohepatitis by Increasing Sirt1 Expression in High-Fat Diet-Induced Obese C57BL/6J Mice
2012
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
2012
The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease
2016
Clinical trial: insulin‐sensitizing agents may reduce consequences of insulin resistance in individuals with non‐alcoholic steatohepatitis
2008
miR-34 – a microRNA replacement therapy is headed to the clinic
2012
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
2011
Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C†
2005
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
2009
MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a
2011
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
2009
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study
2011
Prevalence of primary non‐alcoholic fatty liver disease in a population‐based study and its association with biochemical and anthropometric measures
2006
Clinical Correlates of Histopathology in Pediatric Nonalcoholic Steatohepatitis
2008
Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease
2012
Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid With Vitamin E in Nonalcoholic Steatohepatitis
2006
Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion
2011
Genomics and Signaling Pathways in Hepatocellular Carcinoma
2007
PNPLA3 Variants Specifically Confer Increased Risk for Histologic Nonalcoholic Fatty Liver Disease But Not Metabolic Disease†,‡
2010
Physical Activity Recommendations, Exercise Intensity, and Histological Severity of Nonalcoholic Fatty Liver Disease
2011
NAFLD: A multisystem disease
2015 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis
2010
Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease
2010
Ethnicity and Nonalcoholic Fatty Liver Disease in an Obesity Clinic: The Impact of Triglycerides
2008
Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice
2008 StandoutNobel
Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis
2017
An apoptosis panel for nonalcoholic steatohepatitis diagnosis
2010
Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
2011
Functional and genetic deconstruction of the cellular origin in liver cancer
2015
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Development of micro RNA therapeutics is coming of age
2014
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta‐analysis of the LEAD program
2012
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus
2006
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
2013
Clues from cell metabolism
2010 StandoutNatureNobel
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial
2013
Pilot study of liraglutide effects in non‐alcoholic steatohepatitis and non‐alcoholic fatty liver disease with glucose intolerance in J apanese patients (LEAN ‐J )
2014
A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease
2015
NASH and cryptogenic cirrhosis: A histological analysis
2009
Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients
2009
Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics
2015
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
2016
Imatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells
2004
Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: The SHASTA index
2005
Targeting MYC-Regulated miRNAs to Combat Cancer
2010
Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL −/− clear cell renal carcinoma
2017 StandoutNobel
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
2013
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
2014
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Biology of Gastrointestinal Stromal Tumors
2004 Standout
miRNA Deregulation in Cancer Cells and the Tumor Microenvironment
2016
Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4
2004
Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
2009
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
2009
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
2013
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial
2011
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage
2015
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Weight reduction for non-alcoholic fatty liver disease
2011
Antiretroviral drugs and liver injury
2008
Serum cytokeratin‐18 in the diagnosis of non‐alcoholic steatohepatitis: A meta‐analysis
2013
An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis
2013
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
2007
Pathophysiology of Sleep Apnea
2010 Standout
Cancer Genome Landscapes
2013 StandoutScience
Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research
2012
Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver disease
2015
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing
2011
Myc Enforces Overexpression ofEZH2in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms
2011
No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial
2014
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
2015
Association between vitamin E and non-alcoholic steatohepatitis: a meta-analysis.
2015
Promotion of direct reprogramming by transformation-deficient Myc
2010 StandoutNobel
Nonalcoholic Fatty Liver Disease
2015 Standout
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C
2004
Works of Michael Torbenson being referenced
Prostatic carcinoma with signet ring cells: a clinicopathologic and immunohistochemical analysis of 12 cases, with review of the literature.
1998
Role for Hedgehog signaling in hepatic stellate cell activation and viability
2005
Breath biomarkers and non-alcoholic fatty liver disease: Preliminary observations
2006
Chronic intermittent hypoxia predisposes to liver injury†
2007
β-Catenin Immunohistochemistry Separates Mesenteric Fibromatosis From Gastrointestinal Stromal Tumor and Sclerosing Mesenteritis
2002
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
2009
Primary Liver Carcinoma Arising in People Younger Than 30 Years
2005
Three-dimensional reconstruction of hepatic bridging fibrosis in chronic hepatitis C viral infection
2003
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis
2005
STAT-3 Overexpression and p21 Up-Regulation Accompany Impaired Regeneration of Fatty Livers
2002
Human Hepatocellular Carcinoma in a Mouse Model: Assessment of Tumor Response to Percutaneous Ablation by Using Glyceraldehyde-3-Phosphate Dehydrogenase Antagonists
2012
Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus
2005
Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients
2005
Obstructive Sleep Apnea, Insulin Resistance, and Steatohepatitis in Severe Obesity
2008
Role of liver biopsy in management of chronic hepatitis C: A systematic review
2002
Single-Center Phase II Trial of Transarterial Chemoembolization With Drug-Eluting Beads for Patients With Unresectable Hepatocellular Carcinoma
2009
Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity
2003
Glycogenic Hepatopathy
2006
An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa‐2b combination therapy for chronic hepatitis C
2009
Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers
2009
Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic review
2002
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults
2007
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
2004
Use of Laser Capture Microdissection to Map Hepatitis C Virus–Positive Hepatocytes in Human Liver
2013
Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States
2006
Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic
2006
Occult hepatitis B
2002
Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver
2007
Survivin Overexpression in Hepatocellular Carcinoma Is Associated With p53 Dysregulation
2005
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
2011
Effects of the Type of Embolization Particles on Carboplatin Concentration in Liver Tumors after Transcatheter Arterial Chemoembolization in a Rabbit Model of Liver Cancer
2005
Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice
2003
The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection
2005
Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.
2002
Hepatitis B Virus Replication Induces Methylation of both Host and Viral DNA
2010
mTOR and P70 S6 Kinase Expression in Primary Liver Neoplasms
2004
Non‐alcoholic fatty liver disease contributes to hepatocarcinogenesis in non‐cirrhotic liver: A clinical and pathological study
2013
Role of liver biopsy in management of chronic hepatitis C: A systematic review
2002
Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic review
2002
Causes of death in autopsied liver transplantation patients.
1998
Concurrent Evaluation of p53, β-Catenin, and α-Fetoprotein Expression in Human Hepatocellular Carcinoma
2004
New Intra-arterial Drug Delivery System for the Treatment of Liver Cancer: Preclinical Assessment in a Rabbit Model of Liver Cancer
2006